0000000000613224

AUTHOR

J. Dupuis

showing 3 related works from this author

Overall survival impact of BEACOPP versus ABVD in advanced hodgkin lymphoma: a pooled analysis of 4 randomized trials

2016

IF 6.671; International audience

[SDV.MHEP.HEM] Life Sciences [q-bio]/Human health and pathology/HematologySurvival impact[ SDV.MHEP.HEM ] Life Sciences [q-bio]/Human health and pathology/HematologyABVD[SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/HematologyHodgkin lymphomaBEACOPPChimiothérapie
researchProduct

Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Resear…

2021

Abstract Background Epidemiological studies in atrial fibrillation (AF) illustrate that clinical complexity increase the risk of major adverse outcomes. We aimed to describe European AF patients’ clinical phenotypes and analyse the differential clinical course. Methods We performed a hierarchical cluster analysis based on Ward’s Method and Squared Euclidean Distance using 22 clinical binary variables, identifying the optimal number of clusters. We investigated differences in clinical management, use of healthcare resources and outcomes in a cohort of European AF patients from a Europe-wide observational registry. Results A total of 9363 were available for this analysis. We identified three …

RegistrieResearch Reportmedicine.medical_specialtyMajor adverse outcomeCardiovascular risk factorsCluster analysisRisk FactorsInternal medicineClinical phenotypeAtrial FibrillationEpidemiologyHumansMedicineRegistriesCluster analysiAtrial fibrillation; Clinical management; Clinical phenotypes; Cluster analysis; Major adverse outcomes; Humans; Phenotype; Registries; Research Report; Risk Factors; Atrial FibrillationClinical managementbusiness.industryProportional hazards modelRisk FactorHazard ratioRAtrial fibrillationClinical phenotypesMajor adverse outcomesGeneral Medicinemedicine.diseaseAtrial fibrillationConfidence intervalPhenotypeCohortMedicineObservational studybusinessResearch ArticleHumanBMC Medicine
researchProduct

Prognosis value of baseline total metabolic tumor volume (TMTV) in advanced Hodgkin lymphoma (HL) : Ancillary study of AHL2011 LYSA trial

2016

International audience

[SDV.IB] Life Sciences [q-bio]/Bioengineering[SDV.IB.IMA] Life Sciences [q-bio]/Bioengineering/Imaging[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging[SDV.IB]Life Sciences [q-bio]/Bioengineering[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicine[ SDV.IB ] Life Sciences [q-bio]/BioengineeringComputingMilieux_MISCELLANEOUS[ SDV.IB.IMA ] Life Sciences [q-bio]/Bioengineering/Imaging[SDV.IB.MN] Life Sciences [q-bio]/Bioengineering/Nuclear medicine[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicine
researchProduct